Gary L. Rosner

From MaRDI portal
Person:2233125

Available identifiers

zbMath Open rosner.gary-lMaRDI QIDQ2233125

List of research outcomes





PublicationDate of PublicationType
The lead time distribution when lifetime is subject to competing risks in cancer screening2024-11-27Paper
A Bayesian nonparametric causal inference model for synthesizing randomized clinical trial and real-world evidence2024-10-29Paper
Leveraging real-world evidence for determining performance goals for medical device studies2024-10-29Paper
A Bayesian design for phase I cancer therapeutic vaccine trials2024-10-28Paper
A batch‐effect adjusted Simon's two‐stage design for cancer vaccine clinical studies2023-10-17Paper
Estimation of Progression-Free Survival for All Treated Patients in the Randomized Discontinuation Trial Design2023-02-02Paper
Discovering interactions using covariate informed random partition models2021-10-14Paper
Effect on prediction when modeling covariates in Bayesian nonparametric models2019-08-27Paper
Probability modeling and statistical inference in periodic cancer screening2017-09-21Paper
Semi-parametric Bayesian inference for multi-season baseball data2016-02-16Paper
https://portal.mardi4nfdi.de/entity/Q52561372015-06-22Paper
Inference of long term effects and overdiagnosis in periodic cancer screening2014-04-29Paper
Bayesian enrichment strategies for randomized discontinuation trials2012-06-27Paper
Estimating the term structure with a semiparametric Bayesian hierarchical model: an application to corporate bonds2011-10-28Paper
https://portal.mardi4nfdi.de/entity/Q30028382011-05-24Paper
Bayesian meta-analysis for longitudinal data models using multivariate mixture priors2011-03-01Paper
A Bayesian Approach to Dose-Response Assessment and Synergy and Its Application to In Vitro Dose-Response Studies2011-02-17Paper
Bayesian thinking in biostatistics2011-02-16Paper
Bayesian Nonparametric Nonproportional Hazards Survival Modeling2009-10-19Paper
A Semiparametric Bayesian Model for Repeatedly Repeated Binary Outcomes2009-03-17Paper
Bayesian Optimal Design for Phase II Screening Trials2008-10-15Paper
ANOVA DDP models: a review2008-05-14Paper
Bayesian Inference for the Lead Time in Periodic Cancer Screening2008-01-14Paper
Screening designs for drug development2007-09-27Paper
A Nonparametric Bayesian Model for Inference in Related Longitudinal Studies2007-09-07Paper
Optimal Sampling Times in Population Pharmacokinetic Studies2007-05-30Paper
An ANOVA Model for Dependent Random Measures2006-06-26Paper
MLE and Bayesian Inference of Age-Dependent Sensitivity and Transition Probability in Periodic Screening2006-04-06Paper
A Method for Combining Inference Across Related Nonparametric Bayesian Models2004-09-24Paper
A Bayesian Model for Detecting Acute Change in Nonlinear Profiles2004-06-10Paper
https://portal.mardi4nfdi.de/entity/Q42172551999-07-07Paper
A Bayesian Population Model With Hierarchical Mixture Priors Applied to Blood Count Data1999-06-10Paper
Exact confidence intervals following a group sequential trial: A comparison of methods1988-01-01Paper
Group sequential tests with censored survival data adjusting for covariates1985-01-01Paper
Exact Confidence Intervals Following a Group Sequential Test1984-01-01Paper

Research outcomes over time

This page was built for person: Gary L. Rosner